Annual report pursuant to Section 13 and 15(d)

Condensed Financial Information of Registrant (Details 5)

v2.4.0.6
Condensed Financial Information of Registrant (Details 5) (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Operating activities      
Net income $ 132,582 $ 149,663 $ 100,756
Adjustments to reconcile net income to cash provided by operating activities:      
Share based awards compensation expense 9,692 8,352 4,304
Equity in (income) loss of affiliates (5,651) 3,438 907
Changes in other assets and liabilities (31,148) 60,767 (35,656)
Net cash provided by operating activities 391,201 264,751 176,763
Investing activities      
Net cash used for investing activities (247,067) (136,067) (183,130)
Financing activities      
Proceeds from stock option exercises 444 7,914 2,524
Payroll taxes paid as a result of noncash stock option exercises and restricted stock withholdings (494) (416) (8,972)
Dividends paid to stockholders (95,838) (84,502) (78,643)
Net cash provided by (used for) financing activities (78,414) (106,650) 78,299
Increase in cash and cash equivalents 56,411 27,061 88,333
Cash and cash equivalents:      
Beginning of period 464,997 437,936 349,603
End of period 521,408 464,997 437,936
Cinemark Holdings, Inc.
     
Operating activities      
Net income 130,557 146,120 97,108
Adjustments to reconcile net income to cash provided by operating activities:      
Share based awards compensation expense 666 765 500
Equity in (income) loss of affiliates (131,927) (147,387) (98,031)
Changes in other assets and liabilities (6,659) (561) 9,171
Net cash provided by operating activities (7,363) (1,063) 8,748
Investing activities      
Investments in subsidiaries; Cinemark, Inc. and Cinemark USA, Inc.     (18,000)
Dividends received from subsidiaries; Cinemark, Inc. and Cinemark USA, Inc. 103,175 78,100 58,625
Net cash used for investing activities 103,175 78,100 40,625
Financing activities      
Proceeds from stock option exercises 444 7,914 2,524
Payroll taxes paid as a result of noncash stock option exercises and restricted stock withholdings 494 416 8,972
Dividends paid to stockholders 95,838 84,502 78,643
Net cash provided by (used for) financing activities (95,888) (77,004) (85,091)
Increase in cash and cash equivalents (76) 33 (35,718)
Cash and cash equivalents:      
Beginning of period 232 199 35,917
End of period $ 156 $ 232 $ 199